ARTICLE | Company News
Genentech sales and marketing update
January 10, 1994 8:00 AM UTC
Genentech Inc. (GNE) GNE (South San Francisco) priced Pulmozyme recombinant human DNase at $27 per 2.5 mg ampule, the recommended daily dose, bringing the annualized cost of the cystic fibrosis drug ...